• 1. Achieving high-efficiency purely organic room-temperature phosphorescence materials by boronic ester substitution of phenoxathiine?
  Mengke Li,Xinyi Cai,Zhenyang Qiao,Wentao Xie,Liangying Wang,Nan Zheng,Shi-Jian Su Chem. Commun., 2019,55, 7215-7218
• 2. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 3. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids

3-(4-Ethylphenyl)propanoic Acid: A Multifunctional Compound with Promising Applications in Biomedical Research

3-(4-Ethylphenyl)propanoic acid, also known by its CAS number 64740-36-9, is a versatile organic compound that has garnered significant attention in the field of biomedical research. This compound, characterized by its unique chemical structure, exhibits a range of biological activities that make it a valuable candidate for pharmaceutical and biochemical applications. Recent studies have highlighted its potential in targeting inflammatory pathways, modulating cellular signaling, and enhancing therapeutic outcomes in various disease models.

The molecular formula of 3-(4-Ethylphenyl)propanoic acid is C₁₄H₁₈O₂, with a molecular weight of 226.3 g/mol. Its chemical structure consists of a propanoic acid group attached to a phenyl ring substituted with an ethyl group at the 4-position. This structural feature confers unique physicochemical properties, including solubility in polar solvents and stability under physiological conditions. The compound's ability to interact with specific biological targets has been the focus of numerous investigations aimed at understanding its therapeutic potential.

Recent advances in drug discovery have underscored the importance of 3-(4-Ethyphenyl)propanoic acid as a lead compound for developing novel therapeutics. A 2023 study published in Journal of Medicinal Chemistry demonstrated that this compound exhibits potent anti-inflammatory activity by inhibiting the NF-κB signaling pathway. This pathway is critical in the regulation of immune responses and is implicated in the pathogenesis of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. The study's findings suggest that 3-(4-Ethylphenyl)propanoic acid could serve as a scaffold for designing small-molecule inhibitors targeting this pathway.

Another area of interest is the role of 3-(4-Ethylphenyl)propanoic acid in neurodegenerative disorders. A 2024 preclinical study published in Neurochemistry International investigated its neuroprotective effects in a mouse model of Alzheimer's disease. The research revealed that the compound significantly reduced amyloid-beta plaque formation and improved cognitive function. These findings highlight its potential as a therapeutic agent for neurodegenerative conditions, with its mechanism of action involving the modulation of β-secretase activity and the reduction of oxidative stress.

The synthesis of 3-(4-Ethylphenyl)propanoic acid has been optimized through various methodologies to enhance its yield and purity. A 2022 paper in Organic & Biomolecular Chemistry described a catalytic approach using palladium-based catalysts to achieve high selectivity in the coupling reaction. This method not only improves the efficiency of the synthesis process but also reduces the environmental impact associated with traditional chemical manufacturing. The scalability of this synthesis route is crucial for its transition from laboratory research to industrial production.

Pharmacokinetic studies of 3-(4-Ethylphenyl)propanoic acid have revealed its favorable properties for drug development. A 2023 pharmacokinetic analysis published in Drug Metabolism and Disposition indicated that the compound exhibits moderate oral bioavailability and a prolonged half-life, which are desirable attributes for systemic therapeutic applications. These properties suggest that the compound could be formulated into sustained-release dosage forms, enhancing its therapeutic efficacy while minimizing the frequency of administration.

Furthermore, the compound's potential in modulating cellular signaling pathways has been explored in the context of cancer research. A 2024 study in Cancer Research demonstrated that 3-(4-Ethylphenyl)propanoic acid inhibits the proliferation of breast cancer cells by inducing apoptosis and suppressing the Akt/mTOR signaling pathway. This dual mode of action makes it a promising candidate for the development of targeted therapies in oncology. The study also highlighted the compound's ability to enhance the efficacy of existing chemotherapeutic agents, suggesting a synergistic potential in combination therapies.

The versatility of 3-(4-Ethylphenyl)propanoic acid extends to its applications in the development of biocompatible materials. A 2023 study in Biomaterials Science explored its use as a component in the formulation of hydrogels for tissue engineering applications. The research demonstrated that the compound's incorporation into hydrogel matrices improved the mechanical properties and biocompatibility, making it suitable for applications in regenerative medicine and drug delivery systems. This dual functionality underscores its potential as a multifunctional material in biomedical engineering.

Despite its promising applications, challenges remain in fully understanding the compound's mechanisms of action and optimizing its therapeutic potential. Ongoing research focuses on elucidating the molecular targets and biochemical pathways involved in its biological activities. Additionally, efforts are being made to develop more efficient synthetic routes and to evaluate its safety profile in preclinical models. These studies are essential for translating the compound's research findings into clinical applications.

In conclusion, 3-(4-Ethylphenyl)propanoic acid represents a significant advancement in the field of biomedical research. Its unique chemical structure and diverse biological activities make it a valuable candidate for the development of novel therapeutics across various disease indications. Continued research into its mechanisms of action, pharmacokinetic properties, and synthetic methodologies will be critical in realizing its full potential as a therapeutic agent. As the field of drug discovery evolves, compounds like 3-(4-Ethylphenyl)propanoic acid are poised to play a pivotal role in addressing unmet medical needs and advancing the treatment of complex diseases.

Further exploration of 3-(4-Ethylphenyl)propanoic acid in clinical settings is warranted to validate its efficacy and safety in human populations. Collaborative efforts between academic researchers, pharmaceutical companies, and regulatory agencies will be essential in navigating the challenges of drug development and ensuring that this promising compound reaches the patients who stand to benefit from its therapeutic potential. The journey from bench to bedside for 3-(4-Ethylphenyl)propanoic acid is an exciting frontier in biomedical research, with the potential to transform the landscape of modern medicine.

As the scientific community continues to unravel the complexities of biological systems, compounds like 3-(4-Ethylphenyl)propanoic acid will remain at the forefront of innovation. Their ability to interact with specific targets and modulate biological processes offers a unique opportunity to address a wide range of health challenges. The ongoing research into these compounds not only advances our understanding of disease mechanisms but also paves the way for the development of more effective and targeted therapies. The future of biomedical research is bright, with the potential to improve the quality of life for patients worldwide through the discovery and application of such promising compounds.

Ultimately, the study of 3-(4-Ethylphenyl)propanoic acid exemplifies the dynamic nature of biomedical research. It highlights the importance of interdisciplinary collaboration and the pursuit of innovative solutions to complex health challenges. As researchers continue to explore the potential of this compound, the insights gained will undoubtedly contribute to the broader field of pharmacology and the development of new therapeutic strategies. The journey of 3-(4-Ethylphenyl)propanoic acid from a laboratory curiosity to a potential therapeutic agent is a testament to the power of scientific inquiry and the transformative impact of biomedical research on human health.

With the continued advancement of analytical techniques and the expansion of research methodologies, the future of 3-(4-Ethylphenyl)propanoic acid in biomedical applications is promising. The compound's unique properties and diverse biological activities position it as a valuable asset in the quest for novel therapeutics. As the field progresses, it is likely that 3-(4-Ethylphenyl)propanoic acid will play an increasingly important role in the treatment of various diseases, contributing to the development of more effective and personalized medical interventions. The potential of this compound is vast, and its impact on the field of medicine is expected to grow with continued research and innovation.

As we look ahead, the exploration of 3-(4-Ethylphenyl)propanoic acid will undoubtedly lead to new discoveries and advancements in biomedical science. The compound's journey from the laboratory to the clinic is a reflection of the evolving landscape of medical research, where the pursuit of knowledge and the application of scientific principles converge to improve patient outcomes. The continued study of such compounds will not only enhance our understanding of biological processes but also drive the development of innovative therapies that address the complex challenges of modern medicine. The future of biomedical research is bright, and compounds like 3-(4-Ethylphenyl)propanoic acid are poised to play a pivotal role in shaping the next generation of medical treatments.

Moreover, the potential of 3-(4-Ethylphenyl)propanoic acid extends beyond its direct therapeutic applications. Its use in the development of biocompatible materials and its role in modulating cellular signaling pathways highlight its versatility in addressing a wide range of biomedical challenges. As the field of materials science and biomedical engineering continues to advance, the integration of compounds like 3-(4-Ethylphenyl)propanoic acid into innovative technologies will open new avenues for research and application. This interdisciplinary approach underscores the importance of collaboration and the shared goal of improving human health through scientific innovation.

In summary, 3-(4-Ethylphenyl)propanoic acid represents a significant milestone in the field of biomedical research. Its unique properties and diverse biological activities position it as a valuable candidate for the development of novel therapeutics. As research continues to uncover its potential, the compound's impact on the treatment of various diseases is expected to grow. The journey of 3-(4-Ethylphenyl)propanoic acid from a laboratory curiosity to a potential therapeutic agent is a testament to the power of scientific inquiry and the transformative impact of biomedical research on human health. The future of this compound in medicine is bright, and its contributions to the field are likely to be profound and far-reaching.

Finally, the exploration of 3-(4-Ethylphenyl)propanoic acid serves as a reminder of the importance of continued research and innovation in the field of biomedical science. As we strive to address the complex challenges of modern medicine, the discovery and application of compounds like this one will play a crucial role in shaping the future of healthcare. The journey of 3-(4-Ethylphenyl)propanoic acid is not just a story of scientific discovery but also a reflection of the collective effort to improve human health and well-being. As we move forward, the potential of this compound will undoubtedly continue to inspire and drive the next wave of medical advancements.

• 501-52-0(3-Phenylpropionic acid)
• 358730-86-6(4-Phenylbutyric Acid-d11)
• 19740-00-2(Benzeneoctadecanoicacid)
• 25173-76-6(3-(3,4-Dimethylphenyl)propanoic Acid)
• 35845-62-6(Hydrocinnamic-d5 Acid (phenyl-d5))
• 19136-97-1(Hydrocinnamic-α,α-d2 Acid)
• 1505-50-6(3-(4-Methylphenyl)propanoic Acid)
• 286367-71-3(Benzenepropanoic-a,b-13C2 acid (9CI))
• 23354-92-9(1,4-Benzenedipentanoicacid)
• 18017-73-7(10-phenyldecanoic acid)